中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [38]
青海盐湖研究所 [11]
上海硅酸盐研究所 [6]
合肥物质科学研究院 [5]
采集方式
OAI收割 [60]
内容类型
期刊论文 [60]
发表日期
2026 [1]
2025 [12]
2024 [4]
2023 [1]
2022 [7]
2021 [9]
更多
学科主题
Materials ... [1]
Materials ... [1]
Metallurgy... [1]
筛选
浏览/检索结果:
共60条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemia
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2026, 卷号: 307, 页码: 15
作者:
Xiao, Qitao
;
Wang, Yuxian
;
Shen, Zheyuan
;
Mo, Jun
;
Li, Cong
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2026/04/01
MLL-R AML
Menin inhibitor
thieno[2
d ]pyrimidine
Machine learning
Rational engineering of degradation tail-driven CELMoD-antibody conjugates for precision malignancy therapy
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 12, 页码: 6510-6528
作者:
Guo, Yu
;
Song, Yi
;
Wang, Hanlin
;
Lu, Yang
;
Zhang, Jingyu
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2026/01/29
Degrader-antibody conjugate
Antibody-drug conjugate
Cereblon E3 ligase modulator
Immunomodulatory drug
Molecular glue
Targeted protein degradation
Multiple myeloma
Hematologic malignancy
Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 68, 期号: 20, 页码: 21939-21961
作者:
Lian, Xuanmin
;
Gao, Yue
;
Du, Wenjing
;
Xu, Chengcheng
;
Dong, Xiaowu
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/12/04
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 68, 期号: 20, 页码: 21249-21281
作者:
Jin, Yuheng
;
Liao, Xueyan
;
Zhang, Jingyu
;
Duan, Haiting
;
Xu, Ran
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/12/04
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/ IRAK4 inhibitors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 296, 页码: 23
作者:
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2025/08/20
AML
FLT3/IRAK4 inhibitor
Pyrrolo [2,3-d] pyrimidine
Acquired resistance
Adaptive resistance
Design, synthesis, and evaluation of Menin-targeting compounds for the treatment of acute Myelocytic leukemia (AML)
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 296, 页码: 17
作者:
Mo, Jun
;
Wang, Yuxian
;
Pan, Youlu
;
Xiao, Qitao
;
Zhao, Jinyi
  |  
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2025/08/20
Menin
High binding affinity
Anti-proliferation activity
AML
Discovery of a Selective and Potent BCL6 PROTAC with Efficacious Antiproliferative Activity for the Treatment of Diffuse Large B-Cell Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 68, 期号: 19, 页码: 20180-20206
作者:
Yu, Xiaoli
;
Liao, Xueyan
;
Zhang, Jingyu
;
Wang, Hanlin
;
Li, Xian
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/12/04
Discovery of Piperazine-Amide Derivatives as Highly Potent and Selective RET Inhibitors
期刊论文
OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2025, 页码: 8
作者:
Luo, Penghao
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/12/04
RET
KDR
Selective Inhibitor
Piperazine-amide
Discovery of a ubiquitin-specific protease 10 inhibitor with high binding affinity promoting cell apoptosis via down-regulated CDK4 for the treatment of hepatocellular carcinoma
期刊论文
OAI收割
BIOORGANIC CHEMISTRY, 2025, 卷号: 163, 页码: 17
作者:
Lu, Yang
;
Wang, Wentao
;
Yuan, Cheng
;
Luo, Mengxin
;
Wang, Peipei
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/12/04
HCC
USP10
Deubiquitination
Binding affinity
CDK4
Proteogenomic characterization of non-functional clinically relevant subgroups
期刊论文
OAI收割
CANCER CELL, 2025, 卷号: 43, 期号: 4, 页码: 36
作者:
Ji, Shunrong
;
Cao, Lihua
;
Gao, Jing
;
Du, Yang
;
Ye, Zeng
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2025/06/23